Jupiter Life Line Hospitals (JLHL) Q4 21/22 earnings summary

Executive summary

• FY22 standalone revenue from operations was ₹65,727.85 lakh and profit before tax was ₹10,571.25 lakh; consolidated revenue was ₹73,312.27 lakh and PBT ₹7,731.62 lakh.

• Operations continued amid COVID-related restrictions and higher manpower and purchasing costs, with added spending on staff and medical-team safety and welfare.

Financial highlights

• Standalone revenue from operations rose from ₹46,109.55 lakh in FY21 to ₹65,727.85 lakh in FY22; total income was ₹66,103.30 lakh.

• Standalone profit before tax was ₹10,571.25 lakh versus ₹1,754.93 lakh; profit after tax was ₹8,467.11 lakh versus ₹1,659.31 lakh.

• Consolidated revenue from operations was ₹73,312.27 lakh versus ₹48,616.37 lakh; consolidated PBT was ₹7,731.62 lakh versus ₹155.47 lakh.

• Standalone total expenses were ₹55,532.05 lakh; finance costs were ₹2,923.37 lakh and depreciation and amortisation ₹2,765.87 lakh.

Outlook and guidance

• A 10% dividend was recommended for FY22; ₹846.71 lakh was proposed for transfer to general reserve and ₹6,528.10 lakh for retention in the profit and loss account.

• Capital work in progress included additional departments being set up at Pune and Thane; plans also included purchasing another wind turbine generator at Sangli.